Pawiński T - Search Results

1

Free mycophenolic acid determination in human plasma ultrafiltrate by a validated liquid chromatography-tandem mass spectrometry method.

Łuszczyńska P, Pawiński T, Kunicki PK, Sikorska K, Marszałek R. Łuszczyńska P, et al. Among authors: pawinski t. Biomed Chromatogr. 2017 Oct;31(10). doi: 10.1002/bmc.3976. Epub 2017 May 21. Biomed Chromatogr. 2017. PMID: 28317135

2

Determination of 2-bromo and 2-chloro derivatives of 2'-deoxyadenosine in human blood serum by high performance liquid chromatography.

Gajewska M, Pawiński T, Dzierzgowska-Szmidt A, Grieb P, Ryba M. Gajewska M, et al. Among authors: pawinski t. Acta Pol Pharm. 1994;51(2):109-14. Acta Pol Pharm. 1994. PMID: 7863784

3

Stability of mycophenolic acid in plasma samples from patients during mycophenolate mofetil therapy.

Pawiński T, Shaw LM. Pawiński T, et al. Acta Pol Pharm. 2003 Mar-Apr;60(2):121-4. Acta Pol Pharm. 2003. PMID: 13678320 Free article.

4

A limited sampling strategy for estimating mycophenolic acid area under the curve in adult heart transplant patients treated with concomitant cyclosporine.

Pawinski T, Kunicki PK, Sobieszczanska-Malek M, Gralak B, Szlaska I. Pawinski T, et al. J Clin Pharm Ther. 2009 Feb;34(1):89-101. doi: 10.1111/j.1365-2710.2008.00973.x. J Clin Pharm Ther. 2009. PMID: 19125907

5

Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.

Pawinski T, Luszczynska P, Durlik M, Majchrzak J, Baczkowska T, Chrzanowska M, Sobiak J, Glyda M, Kuriata-Kordek M, Kamińska D, Krajewska M, Klinger M. Pawinski T, et al. Ther Drug Monit. 2013 Dec;35(6):760-9. doi: 10.1097/FTD.0b013e31829b88f5. Ther Drug Monit. 2013. PMID: 24192641

6

Determination of duloxetine in human plasma with proven lack of influence of the major metabolite 4-hydroxyduloxetine.

Kaza M, Gilant E, Filist M, Szlaska I, Pawiński T, Rudzki PJ. Kaza M, et al. Among authors: pawinski t. Clin Biochem. 2014 Sep;47(13-14):1313-5. doi: 10.1016/j.clinbiochem.2014.05.059. Epub 2014 Jun 2. Clin Biochem. 2014. PMID: 24886771

7

A Comparison of the Immunochemical Methods, PETINIA and EMIT, With That of HPLC-UV for the Routine Monitoring of Mycophenolic Acid in Heart Transplant Patients.

Kunicki PK, Pawiński T, Boczek A, Waś J, Bodnar-Broniarczyk M. Kunicki PK, et al. Among authors: pawinski t. Ther Drug Monit. 2015 Jun;37(3):311-8. doi: 10.1097/FTD.0000000000000151. Ther Drug Monit. 2015. PMID: 25380305

8

Therapeutic Drug Monitoring of Mycophenolic Acid in Lupus Nephritis: A Review of Current Literature.

Łuszczyńska P, Pawiński T. Łuszczyńska P, et al. Among authors: pawinski t. Ther Drug Monit. 2015 Dec;37(6):711-7. doi: 10.1097/FTD.0000000000000223. Ther Drug Monit. 2015. PMID: 26034895 Review.

9

Validated HPLC-UV method for determination of naproxen in human plasma with proven selectivity against ibuprofen and paracetamol.

Filist M, Szlaska I, Kaza M, Pawiński T. Filist M, et al. Among authors: pawinski t. Biomed Chromatogr. 2016 Jun;30(6):953-61. doi: 10.1002/bmc.3635. Epub 2015 Nov 11. Biomed Chromatogr. 2016. PMID: 26458096

10

Pharmacokinetics of free and total mycophenolic acid in adult lupus nephritis patients-implications for therapeutic drug monitoring.

Łuszczyńska P, Pawiński T, Kunicki PK, Durlik M, Augustyniak-Bartosik H, Hurkacz M. Łuszczyńska P, et al. Among authors: pawinski t. Eur J Clin Pharmacol. 2019 Mar;75(3):371-379. doi: 10.1007/s00228-018-2599-x. Epub 2018 Nov 14. Eur J Clin Pharmacol. 2019. PMID: 30430214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters